-
Hims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
7 Comments -
FDA approves 1st new class of opioid-free painkillers in over 20 yearsThe FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
17 Comments -
FDA approves ketamine-like nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
-
What are Zyn nicotine pouches? And are they bad for you?The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, especially for young people, and experts say there's little evidence that they help adults quit smoking.
-
Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kindA large new study has shed light on the wider health impacts of taking Ozempic-style drugs.
-
10 of the strangest medical cases from 2024From fungi brewing alcohol in a person's gut to parasitic brain infections, here are some of the oddest medical case reports we covered in 2024.
-
When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says.Interview When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says
Interview -
Simple vaping 'quitline' can help over 40% of young people quit, study findsA study used several strategies to help young adults go from vaping every day to not vaping at all.
-
Scientists make 1-of-a-kind immune cells to guard transplants from attackScientists have designed special immune cells that protect transplanted pancreatic cells from attack in mice.
